US$ 28.81
glp 1 articles GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus Is biased agonism helpful in
Description
The decision depends on your individual health situation, weight loss goals, and how well you've incorporated sustainable habits

According to Evaluate, Lillys retatrutide (GLP-1/GIP/glucagon) hit 2324% in Phase 2, with 2030 sales modeled around $5.6B

But by tackling obesity and its knock-on effects, these medicines may indirectly improve erectile function

Berberine promotes M2 macrophage polarisation through the IL-4-STAT6 signalling pathway in ulcerative colitis treatment

For patients who discontinue GLP-1 medications, several evidence-based strategies can help maintain weight loss and metabolic improvements, though success rates vary considerably
